Mechanistic Study of the Effect of Endothelin SNPs in Microvascular Angina - protocol of the PRIZE Endothelin Sub-Study (2022)

First Author: Abraham G

Attributed to: MICA: A Developmental Trial of Personalised Medicine for Repurposing Zibotentan, a Selective Endothelin A Receptor Blocker, in Microvascular Angina. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.80960

Publication URI: https://www.repository.cam.ac.uk/handle/1810/333540

Type: Journal Article/Review